Formycon Raises Fresh Capital To Drive Biosimilar Development

Funding For COVID-19 Also Received

 
• By Dean Rudge
Euro currency
The €25.75m investment will go towards biosimilar investment • Source: Shutterstock

More from Biosimilars

More from Products